Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.33 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.32 |
| ▸ | TUBB | P07437 | 1/20 | 0.32 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.32 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.32 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.32 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.32 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.32 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.32 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.32 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.32 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.32 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.32 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.32 |
| ▸ | TUBB2B | Q9BVA1 | 1/20 | 0.32 |
| ▸ | TUBB1 | Q9H4B7 | 1/20 | 0.32 |
| ▸ | CFD | P00746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27474843 | 0.85 | CNR1 (0.35) | ALDH1A1PTGDR2SMN1; SMN2 | |
| SCHEMBL1741487 | 0.79 | ALDH1A1 (0.40) | CA2GAAALDH1A1PTGDR2LMNA | |
| SCHEMBL29388180 | 0.79 | ALDH1A1 (0.40) | CA2GAAALDH1A1PTGDR2LMNA | |
| SCHEMBL3421206 | 0.77 | AR (0.40) | GAAALDH1A1 | |
| SCHEMBL3416065 | 0.77 | ESR1 (0.33) | CA2PTGDR2LMNATP53CYP3A4 | |
| SCHEMBL1741610 | 0.77 | ALOX15 (0.42) | CA2GAAALDH1A1LMNAKDM4E | |
| SCHEMBL30259656 | 0.77 | ESR1 (0.44) | CA2GAAALDH1A1TUBB4ATUBB | |
| SCHEMBL727075 | 0.77 | ESR1 (0.44) | CA2GAAALDH1A1TUBB4ATUBB | |
| SCHEMBL3417550 | 0.76 | AR (0.36) | LMNATP53CYP3A4HPGDALOX15 | |
| SCHEMBL3414974 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2597114-B1 | Organic-inorganic composite materials containing triazine rings and electrical devices using the same | HITACHI LTD (JP) | 2017-03-15 | — | — | EP | disclosed |
| US-9090796-B2 | Organic-inorganic composite materials containing triazine rings and electrical devices using the same | HITACHI, LTD. (JP) | 2015-07-28 | — | — | US | disclosed |
| EP-2597114-A1 | Organic-inorganic composite materials containing triazine rings and electrical devices using the same | Hitachi Ltd. (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-20130131248-A1 | ORGANIC-INORGANIC COMPOSITE MATERIALS CONTAINING TRIAZINE RINGS AND ELECTRICAL DEVICES USING THE SAME | HITACHI, LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| US-7767739-B2 | Cyanato group-containing cyclic phosphazene compound and method for producing the same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2010-08-03 | — | — | US | disclosed |
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | FUSHIMI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-02 | — | — | US | disclosed |
| US-6225492-B1 | CONTACTING CYANATE CRUDE PRODUCT SOLUTION COMPRISING CYANATE, UNSUBSTITUTED PHENOL AND NON-ALCOHOLIC SOLVENT WITH POOR SOLVENT CONTAINING ALCOHOL AND WATER TO CRYSTALLIZE OR PRECIPITATE SAID CYANATE | SUMITOMO CHEMICAL CO., LTD. (JP) | 2001-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090170983-A1 | Cyanato Group-Containing Cyclic Phosphazene Compound and Method for Producing The Same | CENPE, CPNE4, MCM3 | CA2 261/4885GAA 3614/4885ALDH1A1 4254/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.